With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
We are seeking one software engineer to join our New York team and work within our Target Identification product area. At BenevolentAI we are developing software systems to enable our machine learning, informatics, and drug discovery programmes. You will apply your software engineering background and rigour to develop and execute a full project, working with more senior software engineers and the various teams within the product area. As part of the Target Identification product area, you will work within the BioQuest team, working on the core engineering of a major bioinformatics data pipeline. This will include working closely with bioinformaticians to understand the functionality that produces the data, as well as with engineers to implement the features within a newly designed extensible, testable, and performant domain structure. You will learn about the design and development of high-performance data pipelines, and how to create production-ready features to run in them, including how to write effective tests and run them within a Continuous Integration/Continuous Deployment process.
Applications close on Monday, February 7th, 2022. Internships can commence anytime from Monday, June 6th 2022. In addition to your CV, please send us a cover letter.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email firstname.lastname@example.org. Thank you.